{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-086130","form_type":"8-K","ticker":"ISPC","cik":"0001558569","company_name":"iSpecimen Inc.","filed_at":"2024-08-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.504335+00:00","generated_at":"2026-05-31T12:15:49.786637+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"iSpecimen Q2 revenue up 76% to $2.86M; net loss narrows to $2.11M","bullets":["Revenue $2.86M (+76% YoY); net loss $2.11M ($0.19/sh) vs $3.5M loss ($0.39/sh) in Q2 2023.","Hired Brielan Smiechowski as SVP of Sales & Business Development.","Next Day Quotes conversion rate 58% to purchase orders.","Cash and securities $2.15M as of June 30, 2024, down from $5.01M at Dec 31, 2023.","Supplier organizations reduced to 105 from 243 at year-end 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-086130","json":"https://secwatch.observer/filing/0001104659-24-086130.json","markdown":"https://secwatch.observer/filing/0001104659-24-086130.md","text":"https://secwatch.observer/filing/0001104659-24-086130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924086130/0001104659-24-086130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1558569/000110465924086130/tm2420908d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T12:15:49.786637+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}